Janus (Q6155940) is a technology entity, and Janus kinase 3/JAK3 is an enzyme involved in immune responses.
1 report, 1 independent
Updated Aug 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Janus (Q6155940) is a technology entity, and Janus kinase 3/JAK3 is an enzyme involved in immune responses.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Janus
programming language
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyAclaris Therapeutics Reports Positive Phase 2a Clinical Trial Results for ATI-2138 Aclaris Therapeutics Inc. (NASDAQ:ACRS) is one of the most promising penny stocks under $5. On July 29, Aclaris Ther